Atazanavir
CAS No. 198904-31-3
Atazanavir( BMS-232632 )
Catalog No. M13109 CAS No. 198904-31-3
A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 86 | In Stock |
|
| 50MG | 113 | In Stock |
|
| 100MG | 194 | In Stock |
|
| 200MG | 291 | In Stock |
|
| 500MG | 492 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtazanavir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
-
DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture; shows synergistic antiviral effects in HIV-infected PBMCs; used to treat and prevent HIV/AIDS.HIV Infection Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-232632
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIVProtease
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number198904-31-3
-
Formula Weight704.8555
-
Molecular FormulaC38H52N6O7
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
-
Chemical Name2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
3-Deazaadenosine hyd...
3-Deazaadenosine hydrochloride is an inhibitor of S-adenosylhomocysteine hydrolase (Ki: 3.9 μM). It has anti-inflammatory, anti-proliferative, and anti-HIV activity.3-Deazaadenosine shows the anti-HIV effect and inhibits p24 antigen in peripheral blood mononuclear (PBMCs) cells infected with HIV-1 isolates (A012 and A018, IC50s: 0.15 and 0.20 μM).
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
(±)-BI-D
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.
Cart
sales@molnova.com